A retrospective case study of sunitinib treatment in three patients with Von Hippel-Lindau disease

Von Hippel-Landau (VHL) disease is characterized by malignant and benign tumors in multiple organs. Sunitinib, a tyrosine kinase inhibitor, has been clinically available for treating sporadic patients with recurrent or unresectable and metastatic clear renal cell carcinomas (cRCCs) and metastatic le...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Biol Ther
Main Authors: Yuan, Gang, Liu, Qiuli, Tong, Dali, Liu, Gaolei, Yi, Yuting, Zhang, Jun, Zhang, Yao, Wang, Lin-ang, Wang, Luofu, Chen, Rongrong, Guan, Yanfang, Yi, Xin, Lan, Weihua, Jiang, Jun
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2018
Assuntos:
Clinical Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6154838/
https://ncbi.nlm.nih.gov/pubmed/29947576
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2018.1470732
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados